Effect of dexmedetomidine on mortality and ventilator-free days in patients requiring mechanical ventilation with sepsis a randomized clinical trial

JAMA - Journal of the American Medical Association

Volumn 317, Issue 13, 2017, Pages 1321-1328

  Kawazoe, Yu ^a   Miyamoto, Kyohei ^b   Morimoto, Takeshi ^c   Yamamoto, Tomonori ^d   Fuke, Akihiro ^e   Hashimoto, Atsunori ^c   Koami, Hiroyuki ^f   Beppu, Satoru ^g   Katayama, Yoichi ^h   Itoh, Makoto ⁱ   Ohta, Yoshinori ^c   Yamamura, Hitoshi ^j  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b WAKAYAMA MEDICAL UNIVERSITY   (Japan)

^c HYOGO COLLEGE OF MEDICINE   (Japan)

^d OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^e OSAKA CITY GENERAL HOSPITAL   (Japan)

^f SAGA UNIVERSITY HOSPITAL   (Japan)

^g NATIONAL HOSPITAL ORGANIZATION KYOTO MEDICAL CENTER   (Japan)

^h SAPPORO MEDICAL UNIVERSITY   (Japan)

ⁱ Yamaguchi Grand Medical Center   (Japan)

^j HIROSAKI UNIVERSITY   (Japan)

more..

Author keywords

[No Author keywords available]

Indexed keywords

DEXMEDETOMIDINE; FENTANYL; MIDAZOLAM; PROPOFOL; HYPNOTIC SEDATIVE AGENT;

ACUTE CORONARY SYNDROME; ADULT; ADVERSE OUTCOME; ARTICLE; ARTIFICIAL VENTILATION; BRADYCARDIA; COMA; CONTROLLED STUDY; DELIRIUM; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEART ARRHYTHMIA; HEART VENTRICLE FIBRILLATION; HOSPITALIZATION; HUMAN; INFLAMMATION; INTENSIVE CARE UNIT; JAPAN; KIDNEY FUNCTION; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; NUTRITIONAL ASSESSMENT; NUTRITIONAL STATUS; OPEN STUDY; OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; SEDATION; SEPSIS; SEQUENTIAL ORGAN FAILURE ASSESSMENT SCORE; SEX DIFFERENCE; SINUS ARREST; TREATMENT DURATION; AGED; CLINICAL TRIAL; MIDDLE AGED; SURVIVAL ANALYSIS; TREATMENT OUTCOME; VENTILATOR WEANING; VERY ELDERLY;

AGED; AGED, 80 AND OVER; DEXMEDETOMIDINE; FEMALE; HUMANS; HYPNOTICS AND SEDATIVES; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; RESPIRATION, ARTIFICIAL; SEPSIS; SURVIVAL ANALYSIS; TREATMENT OUTCOME; VENTILATOR WEANING;

EID: 85017386855     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2017.2088     Document Type: Article

References (30)

1. Jakob SM, Ruokonen E, Grounds RM, et al; Dexmedetomidine for Long-Term Sedation Investigators. Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: Two randomized controlled trials. JAMA. 2012;307(11):1151-1160.
2. Reade MC, Eastwood GM, Bellomo R, et al; DAHLIA Investigators; Australian and New Zealand Intensive Care Society Clinical Trials Group. Effect of dexmedetomidine added to standard care on ventilator-free time in patients with agitated delirium: A randomized clinical trial. JAMA. 2016;315 (14):1460-1468.
3. Taniguchi T, Kidani Y, Kanakura H, Takemoto Y, Yamamoto K. Effects of dexmedetomidine on mortality rate and inflammatory responses to endotoxin-induced shock in rats. Crit Care Med. 2004;32(6):1322-1326.
4. Taniguchi T, Kurita A, Kobayashi K, Yamamoto K, Inaba H. Dose-And time-related effects of dexmedetomidine on mortality and inflammatory responses to endotoxin-induced shock in rats. J Anesth. 2008;22(3):221-228.
5. Herr DL, Sum-Ping ST, England M. ICU sedation after coronary artery bypass graft surgery: dexmedetomidine-based versus propofol-based sedation regimens. J Cardiothorac Vasc Anesth. 2003;17(5):576-584.
6. Frumento RJ, Logginidou HG, Wahlander S, Wagener G, Playford HR, Sladen RN. Dexmedetomidine infusion is associated with enhanced renal function after thoracic surgery [retraction published in J Clin Anesth. 2013;25(5):432]. J Clin Anesth. 2006;18(6):422-426.
7. Aydin C, Bagcivan I, Gursoy S, Altun A, Topcu O, Koyuncu A. Altered spontaneous contractions of the ileum by anesthetic agents in rats exposed to peritonitis. World J Gastroenterol. 2009;15(13): 1620-1624.
8. Pandharipande PP, Sanders RD, Girard TD, et al; MENDS Investigators. Effect of dexmedetomidine versus lorazepam on outcome in patients with sepsis: An a priori-designed analysis of the MENDS randomized controlled trial. Crit Care. 2010;14(2):R38.
9. Bone RC, Balk RA, Cerra FB, et al; ACCP/SCCM Consensus Conference Committee. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest. 1992;101 (6):1644-1655.
10. Sessler CN, Gosnell MS, Grap MJ, et al. The Richmond Agitation-Sedation Scale: validity and reliability in adult intensive care unit patients. Am J Respir Crit Care Med. 2002;166(10):1338-1344.
11. Barr J, Fraser GL, Puntillo K, et al; American College of Critical Care Medicine. Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit. Crit Care Med. 2013;41(1):263-306.
12. Oda S, Aibiki M, Ikeda T, et al; Sepsis Registry Committee of the Japanese Society of Intensive Care Medicine. The Japanese guidelines for the management of sepsis. J Intensive Care. 2014;2(1):55.
13. Vincent JL, de Mendonca A, Cantraine F, et al; Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: Results of a multicenter, prospective study. Crit Care Med. 1998;26(11):1793-1800.
14. Kushimoto S, Gando S, Saitoh D, et al; Japanese Association for Acute Medicine Disseminated Intravascular Coagulation Study Group. Clinical course and outcome of disseminated intravascular coagulation diagnosed by Japanese Association for Acute Medicine criteria: comparison between sepsis and trauma. Thromb Haemost. 2008;100(6): 1099-1105.
15. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: A severity of disease classification system. Crit Care Med. 1985;13(10):818-829.
16. Riker RR, Shehabi Y, Bokesch PM, et al; Safety and Efficacy of Dexmedetomidine Compared With Midazolam Study Group. Dexmedetomidine vs midazolam for sedation of critically ill patients: A randomized trial. JAMA. 2009;301(5):489-499.
17. Ely EW, Shintani A, Truman B, et al. Delirium as a predictor of mortality in mechanically ventilated patients in the intensive care unit. JAMA. 2004;291(14):1753-1762.
18. Skrobik Y, Ahern S, Leblanc M, Marquis F, Awissi DK, Kavanagh BP. Protocolized intensive care unit management of analgesia, sedation, and delirium improves analgesia and subsyndromal delirium rates. Anesth Analg. 2010;111(2):451-463.
19. Schweickert WD, Pohlman MC, Pohlman AS, et al. Early physical and occupational therapy in mechanically ventilated, critically ill patients: A randomised controlled trial. Lancet. 2009;373 (9678):1874-1882.
20. Shehabi Y, Chan L, Kadiman S, et al; Sedation Practice in Intensive Care Evaluation Study Group Investigators. Sedation depth and long-Term mortality in mechanically ventilated critically ill adults: A prospective longitudinal multicentre cohort study. Intensive Care Med. 2013;39(5):910- 918.
21. Girard TD, Kress JP, Fuchs BD, et al. Efficacy and safety of a paired sedation and ventilator weaning protocol for mechanically ventilated patients in intensive care (Awakening and Breathing Controlled Trial): A randomised controlled trial. Lancet. 2008;371(9607):126-134.
22. Vasilevskis EE, Ely EW, Speroff T, Pun BT, Boehm L, Dittus RS. Reducing iatrogenic risks: ICU-Acquired delirium and weakness-crossing the quality chasm. Chest. 2010;138(5):1224-1233.
23. Schmittinger CA, Torgersen C, Luckner G, Schroder DC, Lorenz I, Dunser MW. Adverse cardiac events during catecholamine vasopressor therapy: A prospective observational study. Intensive Care Med. 2012;38(6):950-958.
24. Sander O, Welters ID, Foex P, Sear JW. Impact of prolonged elevated heart rate on incidence of major cardiac events in critically ill patients with a high risk of cardiac complications. Crit Care Med. 2005;33(1):81-88.
25. Schmittinger CA, Dunser MW, Torgersen C, et al. Histologic pathologies of themyocardium in septic shock: A prospective observational study. Shock. 2013;39(4):329-335.
26. Stolk RF, van der Poll T, Angus DC, van der Hoeven JG, Pickkers P, Kox M. Potentially inadvertent immunomodulation: norepinephrine use in sepsis. Am J Respir Crit Care Med. 2016;194 (5):550-558.
27. Ackland GL, Yao ST, Rudiger A, et al. Cardioprotection, attenuated systemic inflammation, and survival benefit of β1-Adrenoceptor blockade in severe sepsis in rats. Crit Care Med. 2010;38(2):388-394.
28. Morelli A, Ertmer C, Westphal M, et al. Effect of heart rate control with esmolol on hemodynamic and clinical outcomes in patients with septic shock: A randomized clinical trial. JAMA. 2013;310(16): 1683-1691.
29. Ebert TJ, Hall JE, Barney JA, Uhrich TD, Colinco MD. The effects of increasing plasma concentrations of dexmedetomidine in humans. Anesthesiology. 2000;93(2):382-394.
30. Singer M, Deutschman CS, Seymour CW, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315 (8):801-810.